|
1
|
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
|
Haematologica
|
2004
|
1.72
|
|
2
|
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.
|
Blood
|
2003
|
1.62
|
|
3
|
Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.
|
Am J Epidemiol
|
2010
|
1.02
|
|
4
|
The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.
|
Am J Blood Res
|
2012
|
0.90
|
|
5
|
Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.
|
BioDrugs
|
2013
|
0.88
|
|
6
|
Body mass index, cardiovascular risk factors, and carotid intima-media thickness in a pediatric population in southern Italy.
|
J Pediatr Gastroenterol Nutr
|
2010
|
0.85
|
|
7
|
Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice.
|
Am J Pathol
|
2009
|
0.82
|
|
8
|
microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus.
|
BMC Infect Dis
|
2014
|
0.81
|
|
9
|
Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis.
|
Mol Cancer
|
2014
|
0.77
|
|
10
|
Influence of the duration of intravenous drug administration on tumor uptake.
|
Front Oncol
|
2013
|
0.77
|
|
11
|
The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration.
|
Dig Dis Sci
|
2012
|
0.76
|
|
12
|
Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation.
|
New Microbiol
|
2007
|
0.75
|